Next Science NXSCF Stock
Next Science Price Chart
Next Science NXSCF Financial and Trading Overview
| Next Science stock price | 0.22 USD |
| Previous Close | 0.4 USD |
| Open | 0.39 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.4 - 0.4 USD |
| 52 Week Range | 0.33 - 0.69 USD |
| Volume | 20 USD |
| Avg. Volume | 4.06K USD |
| Market Cap | 85.7M USD |
| Beta (5Y Monthly) | 0.671418 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NXSCF Valuation Measures
| Enterprise Value | 81.81M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.3169336 |
| Price/Book (mrq) | 10.783783 |
| Enterprise Value/Revenue | 6.985 |
| Enterprise Value/EBITDA | -6.679 |
Trading Information
Next Science Stock Price History
| Beta (5Y Monthly) | 0.671418 |
| 52-Week Change | -25.55% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.69 USD |
| 52 Week Low | 0.33 USD |
| 50-Day Moving Average | 0.43 USD |
| 200-Day Moving Average | 0.47 USD |
NXSCF Share Statistics
| Avg. Volume (3 month) | 4.06K USD |
| Avg. Daily Volume (10-Days) | 7.29K USD |
| Shares Outstanding | 214.79M |
| Float | 101.1M |
| Short Ratio | N/A |
| % Held by Insiders | 51.46% |
| % Held by Institutions | 1.57% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -108.28% |
| Operating Margin (ttm) | -108.066% |
| Gross Margin | 78.11% |
| EBITDA Margin | -104.58% |
Management Effectiveness
| Return on Assets (ttm) | -60.44% |
| Return on Equity (ttm) | -134.91% |
Income Statement
| Revenue (ttm) | 11.71M USD |
| Revenue Per Share (ttm) | 0.06 USD |
| Quarterly Revenue Growth (yoy) | 25.19% |
| Gross Profit (ttm) | 9.15M USD |
| EBITDA | -12249266 USD |
| Net Income Avi to Common (ttm) | -12683312 USD |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.11M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 1.22M USD |
| Total Debt/Equity (mrq) | 15.18 USD |
| Current Ratio (mrq) | 3.17 |
| Book Value Per Share (mrq) | 0.037 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11789770 USD |
| Levered Free Cash Flow (ttm) | -6811286 USD |
Profile of Next Science
| Country | United States |
| State | NSW |
| City | Chatswood |
| Address | The Zenith Building, Tower A |
| ZIP | 2067 |
| Phone | 61 2 8607 5126 |
| Website | https://www.nextscience.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the issues in human health caused by biofilms in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for postoperative wound; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Chatswood, Australia.
Q&A For Next Science Stock
What is a current NXSCF stock price?
Next Science NXSCF stock price today per share is 0.22 USD.
How to purchase Next Science stock?
You can buy NXSCF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Next Science?
The stock symbol or ticker of Next Science is NXSCF.
Which industry does the Next Science company belong to?
The Next Science industry is Drug Manufacturers-Specialty & Generic.
How many shares does Next Science have in circulation?
The max supply of Next Science shares is 294.82M.
What is Next Science Price to Earnings Ratio (PE Ratio)?
Next Science PE Ratio is now.
What was Next Science earnings per share over the trailing 12 months (TTM)?
Next Science EPS is -0.07 USD over the trailing 12 months.
Which sector does the Next Science company belong to?
The Next Science sector is Healthcare.